MBIO
MBIO
NASDAQ · Biotechnology

Mustang Bio Inc

$0.73
+0.00 (+0.29%)
As of Mar 30, 10:13 PM ET ·
Financial Highlights (FY 2025)
Revenue
2.14M
Net Income
217.1K
Gross Margin
51.9%
Profit Margin
10.1%
Rev Growth
+23.7%
D/E Ratio
1.01
Revenue & Net Income
Margin Trends
FY 2025 FY 2024 FY 2023
Gross Margin 51.9% 51.9% 51.9%
Operating Margin 11.7% 12.6% 12.7%
Profit Margin 10.1% 13.0% 12.9%
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 2.14M 2.03M 2.27M
Gross Profit 1.11M 1.06M 1.18M
Operating Income 250.6K 255.3K 286.7K
Net Income 217.1K 264.7K 291.2K
Gross Margin 51.9% 51.9% 51.9%
Operating Margin 11.7% 12.6% 12.7%
Profit Margin 10.1% 13.0% 12.9%
Rev Growth +23.7% +5.3% -4.1%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 2.74M 2.72M 2.29M
Total Equity 2.71M 2.92M 2.95M
D/E Ratio 1.01 0.93 0.78
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA 334.0K 340.0K 365.4K
Free Cash Flow 225.5K 170.6K 157.9K